Bridgeway Capital Management’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-61
| Closed | -$60K | – | 1487 |
|
|
2018
Q2 | $60K | Sell |
61
-36
| -37% | -$35.4K | ﹤0.01% | 1389 |
|
|
2018
Q1 | $499K | Buy |
97
+35
| +56% | +$180K | 0.01% | 1096 |
|
|
2017
Q4 | $335K | Hold |
62
| – | – | ﹤0.01% | 1188 |
|
|
2017
Q3 | $549K | Buy |
62
+1
| +2% | +$8.86K | 0.01% | 1068 |
|
|
2017
Q2 | $458K | Sell |
61
-38
| -38% | -$285K | 0.01% | 1115 |
|
|
2017
Q1 | $631K | Buy |
99
+41
| +71% | +$261K | 0.01% | 980 |
|
|
2016
Q4 | $663K | Sell |
58
-25
| -30% | -$286K | 0.01% | 967 |
|
|
2016
Q3 | $1.15M | Buy |
83
+27
| +48% | +$375K | 0.02% | 739 |
|
|
2016
Q2 | $855K | Buy |
56
+22
| +65% | +$336K | 0.01% | 841 |
|
|
2016
Q1 | $418K | Hold |
34
| – | – | 0.01% | 1116 |
|
|
2015
Q4 | $657K | Hold |
34
| – | – | 0.01% | 948 |
|
|
2015
Q3 | $454K | Buy |
34
+10
| +42% | +$134K | 0.01% | 1081 |
|
|
2015
Q2 | $421K | Buy |
24
+19
| +380% | +$333K | 0.01% | 1148 |
|
|
2015
Q1 | $95K | Buy |
+5
| New | +$95K | ﹤0.01% | 1417 |
|